Accellerated Biologics
Accellerated Biologics is a US medical distribution company specializing in autologous biologics and regenerative medicine devices. It distributes EmCyte PRP and bone marrow systems, TendoNova tenotomy devices, Regenalase lasers, and Redvive photobiomodulation products to orthopedic, sports medicine, and pain management physicians.
- Company typePrivate
- Founded1999
- HeadquartersTegueste, Spain
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Accellerated Biologics does
Accellerated Biologics is a privately held US medical distribution company founded in 1999 and headquartered in Tequesta, Florida. The company specializes in autologous biologics and regenerative medicine, distributing a comprehensive portfolio spanning platelet-rich plasma (PRP) systems, bone marrow concentrate (BMC) systems, adipose tissue processing systems, alpha-2-macroglobulin/fibrinogen concentrates, extracellular vesicle preparations, percutaneous tenotomy devices, dual-delivery laser systems, and consumer photobiomodulation devices. Its primary customers are orthopedic surgeons, sports medicine physicians, interventional pain management specialists, dermatology and aesthetics practitioners, urologists, and OBGYNs across US academic medical centers and specialty practices.
The company's product portfolio centers on third-party manufactured systems that Accellerated Biologics markets and distributes, most notably the EmCyte PurePRP, AbsolutePRP, PureBMC, and SuperShot PRP lines; the TendoNova Ocelot Nano percutaneous tenotomy device (FDA-cleared under K212049); the Regenalase dual-laser system distributed exclusively in the US under a partnership with IPG Medical Corporation; and the in-house RegeniSTAT platelet analyzer that uses AI-assisted Viscoelastic Focusing technology for point-of-care PRP quality validation. Supporting equipment includes the Executive Series Centrifuge II and the AspiraDome aspiration device, while the Redvive PBM line comprises FDA Class II consumer-grade red and near-infrared light therapy devices. EmCyte systems have been independently validated by The Steadman Clinic's ProofPoint Biologics division, demonstrating 9-20 billion platelet yields from 7mL samples and over 9.1x total nucleated cell concentration in BMC processing within under 10 minutes at the point of care.
Accellerated Biologics generates revenue through three streams: (1) hardware and consumable biologics sales to physicians, clinics, and healthcare providers via a direct field sales force and an authorized distributor network across the United States, with most enterprise pricing conducted via quote-based negotiations; (2) clinical education and training delivered through the Regenerative Medicine Training Institute (RMTI), with tuition of $1,295 per attendee for CME-approved hands-on courses; and (3) digital marketing services sold to physician clients, encompassing social media management, review growth via Broadly, patient education brochures, content writing, and marketing automation. The company supplements its sales motion with financing through Financial Partners Group and maintains active booth presence at major orthopedic and PM&R conferences including AOSSM and AAPM&R.
Accellerated Biologics firmographics
Firmographics- Name
- Accellerated Biologics
- Legal name
- Accellerated Biologics
- Website
- https://accelleratedbiologics.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Accellerated Biologics is a US medical distribution company specializing in autologous biologics and regenerative medicine devices. It distributes EmCyte PRP and bone marrow systems, TendoNova tenotomy devices, Regenalase lasers, and Redvive photobiomodulation products to orthopedic, sports medicine, and pain management physicians.
- Ownership category
- akta.pro rank
Accellerated Biologics industry classification
Industry- Product category
- Regenerative Medicine Medical Devices
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Accellerated Biologics is headquartered
LocationHeadquarters
- HQ city
- Tegueste
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Accellerated Biologics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Biologics and Medical Device Product Sales: AcCELLerated Biologics generates revenue through the sale of regenerative medicine biologics (PRP, Bone Marrow Concentrate, Adipose-derived products) and medical devices (centrifuges, lasers, analyzers, tenotomy devices) to physicians, clinics, and healthcare providers. Products are sold through direct sales, distributor networks, and e-commerce for consumer wellness devices. The company also provides associated consumable kits and accessories as recurring revenue streams.
- Education and Training Services: Through the Regenerative Medicine Training Institute (RMTI), the company offers CME-approved hands-on training courses for physicians including PRP, bone marrow aspirate, and adipose tissue techniques. Tuition for courses such as the RMTI Course Incorporating Orthobiologics is priced at $1,295 per attendee, with small class sizes of approximately 30 participants.
- Marketing Services for Physician Practices: The company offers a suite of marketing services to physician clients including social media management, patient education brochures, review growth, digital footprint management, content and blog writing, and marketing automation. These services represent an additional revenue stream targeting the same physician customer base.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Redvive 60 red light therapy panel |
| Unit Pricing | Pay-as-you-go | Redvive 300 full body red light therapy panel |
| Unit Pricing | Pay-as-you-go | Redvive 300 Adjustable Stand |
| Unit Pricing | Pay-as-you-go | Redvive Halo Hat |
| Other | Pay-as-you-go | RMTI Orthobiologics Training Course |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Accellerated Biologics product offering
Product offeringCore offering
Accellerated Biologics is a U.S. medical distribution company that supplies regenerative medicine biologics and medical devices to physicians and healthcare providers. The portfolio spans platelet-rich plasma (PRP) systems, bone marrow concentrate devices, adipose tissue processing kits, A2M/fibrinogen kits, photobiomodulation red light therapy devices, dual-delivery musculoskeletal laser systems, and a point-of-care platelet analyzer. The company also operates the Regenerative Medicine Training Institute (RMTI) for physician education and offers marketing services to medical practices.
Product overview
Accellerated Biologics offers a unified portfolio of autologous biologics products and medical devices centered on regenerative medicine. The core offering includes multiple PRP (Platelet Rich Plasma) systems (PurePRP® GS30/GS60/GS120 Pure II, AbsolutePRP GS30/GS60/GS120, SuperShot® PRP, AbsolutePRP Gold), bone marrow concentrate systems (PureBMC®, AbsoluteBMC® GSBMA30), adipose tissue processing (MAPS™ Micro Adipose Processing System, Adipose Progenikine PK25/PK50), and A2M fibrinogen products. Supporting these biologics are medical devices including the TendoNova Ocelot Nano for tendon treatment, REGENALASE™ dual-delivery laser system for musculoskeletal conditions, and Redvive PBM red light therapy devices (RV 60, RV 300, RV Halo Hat). The RegeniSTAT™ Platelet Analyzer provides real-time quality analysis of PRP output. The company serves orthopedics, sports medicine, pain management, dermatology, plastic surgery, urology, and OBGYN providers with products designed for minimally manipulated autologous cell therapies.
Differentiator
Problem solved
Functional benefit
Brands
- PureBMC: Pure Bone Marrow Concentrate product line for closed, sterile processing of bone marrow cells
- AbsolutePRP
- PurePRP
- SuperShot PRP
- MAPS
- RegeniSTAT
- Redvive
- REGENALASE
- TendoNova Ocelot Nano
- Regenerative Medicine Training Institute (RMTI)
Products and services
- PureBMC Pure Bone Marrow Concentrate
Companies that use Accellerated Biologics
Customer profileNamed customers22 records
Segments5 records
Ideal customer profiles3 records
Accellerated Biologics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature8 records
Accellerated Biologics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- Forever LabscoreAcCELLerated Biologics and Forever Labs announced a strategic partnership in June 2026 to advance stem cell storage and regenerative medicine solutions in the US. The collaboration combines biologic therapies with adult stem cell collection and cryopreservation services. Initial focus areas include physician education, training initiatives, and integrated service offerings for clinics, with Florida identified as a key market due to its supportive regulatory framework for stem cell applications.
- IPG Medical CorporationcoreAcCELLerated Biologics serves as the exclusive US distributor of the Regenalase Laser System from IPG Medical Corporation. The Regenalase is a dual-delivery laser platform for musculoskeletal tissue treatment. The partnership was announced in August 2025, expanding AcCELLerated Biologics' device portfolio to include advanced laser therapy alongside its biologics offerings.
- BroadlysupportingAcCELLerated Biologics partnered with Broadly to provide review growth solutions to physician clients. Broadly's platform automates patient follow-up for review collection, enabling practices to build online reviews and improve search engine rankings. The partnership integrates review management into AcCELLerated Biologics' broader marketing services offering.
- EmCyte CorporationcoreAcCELLerated Biologics distributes EmCyte biologic processing systems including PurePRP, AbsolutePRP, and PureBMC product lines. These EmCyte systems are central to AcCELLerated Biologics' product portfolio, offering validated high platelet concentration performance. Independent testing by institutions including The Steadman Clinic validates EmCyte systems' superiority in platelet yields and cell concentration.
- TendoNovacoreAcCELLerated Biologics distributes the TendoNova Ocelot Nano device, an FDA-cleared percutaneous tenotomy system. The Ocelot Nano uses a rapidly oscillating stainless-steel cutter for tendon debridement and fragmentation, with a dedicated port for targeted biologic delivery post-procedure. The device complements AcCELLerated Biologics' PRP and biologics portfolio.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Accellerated Biologics competitors and assessment
Company assessmentDirect peers
- EmCyte Corporation: EmCyte is the manufacturer of PurePRP, AbsolutePRP, and PureBMC systems that AcCELLerated Biologics distributes, making it both supplier and closest functional peer in the PRP/biologics category.
- Apex Biologix: Apex Biologix distributes PRP kits and provides regenerative medicine training to physicians, directly overlapping AcCELLerated Biologics' PRP distribution and RMTI-style education model.
- Royal Biologics: Royal Biologics is a regenerative medicine distributor offering autologous biologics kits (PRP, BMAC) to orthopedic and pain physicians, directly competing in the same product categories.
- Regenexx: Regenexx operates a network of regenerative medicine physician clinics using autologous biologics — a competing go-to-market model in orthobiologics that intersects with the same end-market of orthopedic and sports medicine physicians.
- Isto Biologics: Isto Biologics develops and distributes autologous and allograft orthobiologics for spine, sports medicine, and orthopedic surgeons — directly comparable to AcCELLerated Biologics' biologics portfolio.
Broad incumbents
- Bioventus: Bioventus is a publicly-traded orthobiologics company offering bone graft, PRP, and HA products that compete with AcCELLerated Biologics' portfolio in sports medicine and orthopedic channels.
- Arthrex: Arthrex is a large orthopedic surgical device and biologics company with its own PRP/orthobiologics line, representing a well-capitalized incumbent in AcCELLerated Biologics' core orthopedic end market.
- Terumo BCT: Terumo BCT manufactures cell processing and blood component separation systems, overlapping with AcCELLerated Biologics' PRP/BMC processing technology stack as a broader life-sciences incumbent.
- Zimmer Biomet: Zimmer Biomet is a global orthopedic medtech leader with biologics offerings (PRP, bone graft substitutes), competing for the same hospital and ambulatory surgery center customers.
- Stryker: Stryker is a diversified orthopedic and surgical device incumbent selling into the same physician and hospital channels targeted by AcCELLerated Biologics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Accellerated Biologics social profiles
Digital presenceAccellerated Biologics compliance and trust
Trust signalCompliance2 records
Accellerated Biologics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accellerated Biologics leadership team
Management profileNumber of profiles
Profiles8 records
Accellerated Biologics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accellerated Biologics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accellerated Biologics
What does Accellerated Biologics do?
Accellerated Biologics is a U.S. medical distribution company that supplies regenerative medicine biologics and medical devices to physicians and healthcare providers. The portfolio spans platelet-rich plasma (PRP) systems, bone marrow concentrate devices, adipose tissue processing kits, A2M/fibrinogen kits, photobiomodulation red light therapy devices, dual-delivery musculoskeletal laser systems, and a point-of-care platelet analyzer. The company also operates the Regenerative Medicine Training Institute (RMTI) for physician education and offers marketing services to medical practices.
Is Accellerated Biologics a public or private company?
Accellerated Biologics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Accellerated Biologics founded?
Accellerated Biologics was founded in 1999. It employs 1 to 10 people.
Where is Accellerated Biologics based?
Accellerated Biologics is headquartered in Tegueste, Spain, in the Europe region.
How does Accellerated Biologics make money?
Three revenue lines are on record. Biologics and Medical Device Product Sales are the primary driver. The others are education and Training Services and marketing Services for Physician Practices.
Who are Accellerated Biologics's main competitors?
Direct peers on record are EmCyte Corporation, Apex Biologix, Royal Biologics, Regenexx and Isto Biologics. Broad incumbents are Bioventus, Arthrex, Terumo BCT, Zimmer Biomet and Stryker.
Does Accellerated Biologics have an API?
No public API is recorded for Accellerated Biologics.
What industry is Accellerated Biologics in?
Accellerated Biologics's product category is Regenerative Medicine Medical Devices. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 423450 and its SIC code is 5047.